Jun 24 - 28, 2023
Montréal, Canada
Recap:
Siemens Healthineers at ISTH 2023
31st Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Your trusted partner in hemostasis testing. Today, tomorrow, and in the future.
See you at ISTH 2024!
Thank you for joining us at ISTH 2023 in Montréal!
We look forward to seeing you again next year in Bangkok, Thailand, 22–26 June 2024. We're excited to showcase our coagulation testing portfolio for the first time in Asia.
Coagulation Analyzers
Trusted coagulation analyzers designed to meet your lab's needs
In order to assist laboratories in managing the complexity and growing volume of hemostasis testing, we have evolved our coagulation analyzer portfolio with the latest technologies to streamline processes.
Introducing CN-3000/6000 Systems to North America1
With the smallest footprint available in the hemostasis market,2 a throughput of 450 PT tests per hour, intelligent software, and flexible connectivity and throughput options, they are our smallest,2 fastest,3 smartest4 and most flexible5 hemostasis analyzers yet. Join this session to experience the new CN-3000 and CN-6000 Hemostasis Systems1 from Siemens Healthineers and hear about first customers' experiences.
Scalable coagulation analyzer portfolio
Our coagulation analyzer portfolio streamlines testing and allows standardized results across low-, mid-, and high-volume analyzers for multisite labs.
CN-3000 and CN-6000 Systems1
Mid- and high-volume coagulation systems that combine fast, smart, and flexible testing in a small footprint.
CS-2500 System
Mid-volume, fully automated solution featuring smartly designed technologies, including PSI® checks.
CS-5100 System
High-volume, fully automated solution featuring PSI® technology and automation connectivity.
Lab automation
Streamline coagulation testing workflows with single- or multidisciplinary lab automation
Our scalable, configurable portfolio of automated lab solutions supports varying needs, space, and discipline-specific requirements to enhance workflows in any-sized lab.
Learn how your lab could benefit from automation
Automating hemostasis testing assists in streamline your processes, reduces hands-on time, supports efficient testing, and expands your testing menu. Hear how two customers from Falun, Finland, and Aarau, Switzerland, enhanced their hemostasis testing by connecting coagulation analyzers to an automation track.
Explore lab automation solutions
Whether you require a stand-alone hemostasis solution, automated hemostasis testing, or hemostasis testing combined with specific or multidisciplinary testing enhanced by digitalization, we can provide it all.
Laboratory automation
A broad portfolio of scalable and customizable automation solutions to streamline single-discipline or multidisciplinary workflows in labs of all sizes.
Step into the world of lab automation
Step into the world of lab automation
Digitalization in hemostasis testing
Go beyond hemostasis testing
Atellica® Diagnostics IT offers easy-to-use solutions that can maximize the effectiveness of your laboratory and staff. Powerful features and intuitive design help you to quickly identify, investigate, and resolve your most pressing operational issues. Our integrated decision support systems enable labs and the physicians they support to make confident decisions and provide the best patient care.
Explore the potential of AI in hemostasis testing
By combining relevant patient information, labs have the potential to generate disease-specific patient probability scores to help alert physicians to areas of concern and/or potential patient risk or diagnosis. In his recent poster, Dr. Raj Gopalan explored the potential of AI in predicting the risk of coagulation disorders. Located below is a complimentary downloadable poster that unpacks the details around AI-driven clinical decision support in coagulation.
IT solutions that can help optimize your lab processes
Let us help you digitalize your lab operations.
Atellica Diagnostics IT solutions
Scalable, easy-to-use solutions to simplify tasks and maximize the effectiveness of your laboratory and staff.
Discover solutions that elevate your lab
Coagulation Assays
Better patient outcomes from diagnosis to therapy management
Our broad portfolio of routine and specialty hemostasis assays supports physicians in making sound diagnostic and therapeutic decisions. To help you simplify tasks and improve workflows, we continuously expand our portfolio with new technologies and ready-to-use solutions.
Improve bleeding patient management
While the majority of von Willebrand disease (VWD) patients suffer from a congenital, lifelong bleeding disorder, certain chronic diseases and therapies can lead to acquired VWD. Check out our resources for recent testing guidelines and advancements in VWD diagnostics.
Explore our unparalleled bleeding portfolio
Streamline the diagnostic testing arond primary and secondary hemostasis with tests for acquired and congenital bleeding risk assessment from one provider.
Now available in the U.S.: INNOVANCE VWF Ac and vWF Ag assays
Take VWF diagnostics to the next level with a highly innovative, sensitive and precise initial von Willebrand disease testing panel.
INNOVANCE PFA-2001 System
A platelet function analyzer for automated assessment of inherited, acquired, or drug-induced platelet dysfunction.
Integrated platelet aggregation testing1
An innovation that makes aggregation testing more manageable, reliable, and standardized.
Bleeding portfolio overview
A comprehensive bleeding risk assessment portfolio of systems and assays.
Streamline Anti-Xa testing
To monitor and manage bleeding risks, safeguard anticoagulant therapies such as heparin or direct oral anticoagulants (DOACs) by testing patients for a growing number of agents using just one assay.
Poster: Preliminary performance data of an Anti-Xa assay for the quantitative determination of edoxaban
Abstract: The INNOVANCE Anti-Xa assay1 in combination with drug-specific standards and controls is used for the quantitative determination of heparins, rivaroxaban, and apixaban in human citrated plasma. Respective applications for automated analyzers are based on a chromogenic assay principle. For the quantitative determination of edoxaban, new applications employing edoxaban-containing standards and controls are under development. Aim of the studies was to assess the performance of these new edoxaban applications.6
INNOVANCE Anti-Xa assay1
An assay that simplifies anticoagulant testing, with a combined solution for heparin and DOAC testing. Test for UFH, LMW, apixaban, rivaroxaban, and edoxaban with just one assay.6
Gain insights on the Anti-Xa assay
Educational programs
Stay up to date in hemostasis testing
Because the diagnostics landscape is constantly changing and hemostasis has a significant impact across disciplines, keeping up with the latest trends is crucial. Leverage our educational and scientific resources to stay up to date in hemostasis testing.
As a leader in hemostasis testing, Siemens Healthineers passionately supports hemostasis research and continued education through our Hemostasis Learning Institute.
Register for the Siemens Healthineers Hemostasis Learning Institute!
The Siemens Healthineers Hemostasis Learning Institute offers self-paced, on-demand courses developed in collaboration with experts in the field and feature a constantly evolving curriculum to ensure topics and guidelines stay relevant.
At the Hemostasis Learning Institute, you will be able to:
- Personalize your education based on your knowledge level and schedule.
- Complete courses on our easy-to-use platform to earn your certificate.
- Receive access to the next level of learning.
The first classes launch in 2023.
Benefit from more training opportunities
Watch webinars with independent third-party speakers or Siemens Healthineers experts.
ISTH Academy
Browse our industry portal for ISTH-approved, free educational content ranging from basic coagulation concepts to current scientific topics.
IVDR webinars and trainings
Watch recordings of our ISTH presentation theater sessions on IVDR implementation or book a training class.
Hemostasis and COVID-19
Learn about the effect of COVID-19 on coagulation.
Hemostasis Science Weeks
Join renowned speakers in five sessions to gain insights into the latest developments in hemostasis testing and the management of coagulation disorders.
Register for educational and scientific online courses today!
Thanks for your interest in the Hemostasis Learning Institute. Register today to begin your educational hemostasis journey.
See you in 2024!
Trusted hemostasis solutions. Proven outcomes. One common factor.
Siemens Healthineers provides flexible, expansive portfolio solutions across the core lab, including hemostasis, clinical chemistry, immunoassay, hematology, urinalysis, automation, and IT solutions, combined with vast experience and service excellence, to meet the needs of labs in all segments.
Our 40+ years of leadership in hemostasis testing is built on a strong scientific legacy of innovation in reagent development. Our hemostasis testing portfolio comprises >60 assays, including trusted, ready-to-use, highly precise INNOVANCE® assays, as well as a scalable selection of Siemens Healthineers and Sysmex coagulation analyzers. Whether you require a stand-alone hemostasis solution, automated hemostasis testing, or hemostasis testing combined with specific or multidisciplinary testing enhanced by digitalization, we can provide it all.
We look forward to meeting you in Bangkok at ISTH 2024!
Share
Do you find this page interesting? Share it with your peers.
1
The products/features/applications mentioned here are not commercially available in all countries and are subject to local regulations. Their future availability cannot be guaranteed. Not available for sale in the U.S.
2
As of April 2021. Footprint compared to competitor systems in the same volume class as listed on https://www.captodayonline.com/ and in the COBAS T 511 and COBAS T 711 coagulation analyzers brochure, Roche, 2018.
3
As of April 2021. Sysmex CN-6000 System throughput: 400 PT/APTT; Sysmex CN-3000 System throughput: 215 PT/APTT. Throughput evaluated against systems in the same volume class as listed on https://www.captodayonline.com/ As of April 2021. Sysmex CN-6000 System throughput: 400 PT/APTT; Sysmex CN-3000 System throughput: 215 PT/APTT. Throughput evaluated against systems in the same volume class as listed on https://www.captodayonline.com/ and in the COBAS T 511 and COBAS T 711 coagulation analyzers brochure, Roche, 2018.
4
As of April 2021.
5
Connects to Aptio Automation, FLEXLAB, and FLEXLAB FOR HIGH THROUGHPUT tracks. Other third-party connectivity options are under development. Their future availability cannot be guaranteed.
6
Application for edoxoaban is under development and not available for sale. Its future availability cannot be guaranteed.
Atellica, INNOVANCE, PSI, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. All other trademarks and brands are the property of their respective owners.
CN-3000 System and CN-6000 System refera to Automated Blood Coagulation Analyzer CN-3000 and Automated Blood Coagulation Analyzer CN-6000 respectively. CN-3000/6000 Systems refers to Automated Blood Coagulation Analyzer CN-3000 and Automated Blood Coagulation Analyzer CN-6000. CS-2500 System and CS-5100 System refers to Automated Blood Coagulation Analyzer CS-2500 and Automated Blood Coagulation Analyzer CS-5100 respectively.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.